OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$7.34−1.53 (-17.25%)
Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –
OptimizeRx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
OptimizeRx's enterprise value was $163.46M on Nov 11, 2026, against $292.49M a year earlier. Over the last 5 years it ranged from $80.23M to $1.02B, with a median of $196.08M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $163.46M | -30.9% |
| 2025 | Dec 31, 2025 | $236.53M | +120.5% |
| 2024 | Dec 31, 2024 | $107.27M | -46.2% |
| 2023 | Dec 29, 2023 | $199.57M | -12.5% |
| 2022 | Dec 30, 2022 | $227.99M | -77.6% |
| 2021 | Dec 31, 2021 | $1.02B | +122.0% |
| 2020 | Dec 31, 2020 | $457.62M | +299.9% |
| 2019 | Dec 31, 2019 | $114.44M | -2.8% |
| 2018 | Dec 31, 2018 | $117.80M | +187.7% |
| 2017 | Dec 29, 2017 | $40.95M | +148.8% |
| 2016 | Dec 30, 2016 | $16.46M | -39.5% |
| 2015 | Dec 31, 2015 | $27.23M | +12.0% |
| 2014 | Dec 31, 2014 | $24.31M | -46.3% |
| 2013 | Dec 31, 2013 | $45.28M | – |
See a number that looks wrong?